Michael D. Hogarty
Division of Oncology
The Children's Hospital of Philadelphia
Department of Pediatrics
University of Pennsylvania School of Medicine
USA
Name/email consistency: high
- Mcl1 becomes ubiquitin-ous: new opportunities to antagonize a pro-survival protein. Hogarty, M.D. Cell Res. (2010)
- ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma. Hogarty, M.D., Norris, M.D., Davis, K., Liu, X., Evageliou, N.F., Hayes, C.S., Pawel, B., Guo, R., Zhao, H., Sekyere, E., Keating, J., Thomas, W., Cheng, N.C., Murray, J., Smith, J., Sutton, R., Venn, N., London, W.B., Buxton, A., Gilmour, S.K., Marshall, G.M., Haber, M. Cancer Res. (2008)
- The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification. Hogarty, M.D. Cancer Lett. (2003)
- No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3. Hogarty, M.D., Winter, C.L., Liu, X., Guo, C., White, P.S., Look, A.T., Brodeur, G.M., Maris, J.M. Cancer Res. (2002)
- Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas. Hogarty, M.D., Liu, X., Guo, C., Thompson, P.M., Weiss, M.J., White, P.S., Sulman, E.P., Brodeur, G.M., Maris, J.M. Med. Pediatr. Oncol. (2000)
- BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification. Hogarty, M.D., Liu, X., Thompson, P.M., White, P.S., Sulman, E.P., Maris, J.M., Brodeur, G.M. Med. Pediatr. Oncol. (2000)
